Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 2
2022 pubmed 20 citations

Lactational Amenorrhea: Neuroendocrine Pathways Controlling Fertility and Bone Turnover.

Calik-Ksepka. Anna A; Stradczuk. Monika M; Czarnecka. Karolina K; Grymowicz. Monika M; Smolarczyk. Roman R

Key Findings

  • Hyperprolactinemia during lactation suppresses hypothalamic Kiss1 (kisspeptin) neurons, disrupting GnRH/LH pulsatility and causing amenorrhea.
  • Lactational bone loss is a normal, reversible process that supplies calcium to the infant and does not increase long‑term osteoporosis risk in most women.
  • LAM is an effective contraceptive only when specific breastfeeding frequency and exclusivity criteria are met; casual breastfeeding alone is insufficient.

Practical Outcomes

  • For biohackers interested in fertility control, relying solely on breastfeeding isn’t enough—follow the exact LAM guidelines (exclusive nursing, frequent suckling, infant <6 months) to use it as contraception. There’s no evidence here that supplementing kisspeptin‑10 will counteract lactational amenorrhea, so focus on managing prolactin levels or breastfeeding patterns rather than trying peptide interventions.

Summary

During breastfeeding, high prolactin levels shut down kisspeptin neurons in the brain, which stops the normal GnRH and LH hormone pulses needed for ovulation, causing temporary infertility (lactational amenorrhea). This also leads to increased bone turnover to supply calcium to the baby, but bone density usually recovers after weaning. The lactational amenorrhea method (LAM) can be a reliable, low‑cost birth control if strict breastfeeding patterns are followed, but it’s not the same as just nursing.

Abstract

Lactation is a physiological state of hyperprolactinemia and associated amenorrhea. Despite the fact that exact mechanisms standing behind the hypothalamus-pituitary-ovarian axis during lactation are still not clear, a general overview of events leading to amenorrhea may be suggested. Suckling remains the most important stimulus maintaining suppressive effect on ovaries after pregnancy. Breastfeeding is accompanied by high levels of prolactin, which remain higher than normal until the frequency and duration of daily suckling decreases and allows normal menstrual function resumption. Hyperprolactinemia induces the suppression of hypothalamic Kiss1 neurons that directly control the pulsatile release of GnRH. Disruption in the pulsatile manner of GnRH secretion results in a strongly decreased frequency of corresponding LH pulses. Inadequate LH secretion and lack of pre-ovulatory surge inhibit the progression of the follicular phase of a menstrual cycle and result in anovulation and amenorrhea. The main consequences of lactational amenorrhea are connected with fertility issues and increased bone turnover. Provided the fulfillment of all the established conditions of its use, the lactational amenorrhea method (LAM) efficiently protects against pregnancy. Because of its accessibility and lack of additional associated costs, LAM might be especially beneficial in low-income, developing countries, where modern contraception is hard to obtain. Breastfeeding alone is not equal to the LAM method, and therefore, it is not enough to successfully protect against conception. That is why LAM promotion should primarily focus on conditions under which its use is safe and effective. More studies on larger study groups should be conducted to determine and confirm the impact of behavioral factors, like suckling parameters, on the LAM efficacy. Lactational bone loss is a physiologic mechanism that enables providing a sufficient amount of calcium to the newborn. Despite the decline in bone mass during breastfeeding, it rebuilds after weaning and is not associated with a postmenopausal decrease in BMD and osteoporosis risk. Therefore, it should be a matter of concern only for lactating women with additional risk factors or with low BMD before pregnancy. The review summarizes the effect that breastfeeding exerts on the hypothalamus-pituitary axis as well as fertility and bone turnover aspects of lactational amenorrhea. We discuss the possibility of the use of lactation as contraception, along with this method's prevalence, efficacy, and influencing factors. We also review the literature on the topic of lactational bone loss: its mechanism, severity, and persistence throughout life.

Study Information

Provider

pubmed

Year

2022

Date

2022-01-31T00:00:00.000Z

DOI

10.3390/ijms23031633

Citations

20

References

129